Power Law company profile

Dyne Therapeutics

Biotech & Life Sciences · Waltham, United States · Founded 2017 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.94B

Market cap · Apr/2026

Investors

10 investors on Dyne Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

Series A 9 investors entered at this stage

Global footprint

Web traffic by country

21K monthly visits
across markets

🇺🇸 United States86.7%

🇬🇧 United Kingdom6.2%

🇮🇳 India6.2%

🏳️ Korea1.4%

🏳️ Republic of1%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo